Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Warrants Presented at Fair Value

Warrants Presented at Fair Value

12 Months Ended

Dec. 31, 2023

Warrants Presented at Fair Value [Abstract]

WARRANTS PRESENTED AT FAIR VALUE

NOTE 11:

Warrants presented at fair value

The Company’s outstanding warrants classified as a liability as of December 31, 2022 are as follows:

Outstanding		Exercise price			Issuance year		Exercisable through		Fair value

	120,000	$	0.92	(*)		2014		(***)	$	1	(****)
	675,926		(**	)		2017		2024		14,785	(****)
	1,411,765		0.17			2019		2024		673	(****)

	2,207,691								$	15,459	(*****)

(*)	Subject to changes as describe in the agreement.

(**)	Less than $0.01.

(***)

M&A or qualified public offering as described in the agreement.

(****)

Issued in connection with the 2019, 2017 and 2014 arrangements.

(*****)

Contains warrants presented at fair value within non-current liabilities.

The Company’s outstanding warrants classified as a liability as of December 31, 2023 are as follows:

Outstanding		Exercise price			Issuance year		Exercisable through		Fair value

	120,000	$	0.92	(*)		2014		(***)	$	—	(****)
	675,926		(**	)		2017		2024		1,926	(****)
	1,411,765		0.17			2019		2024		—	(****)

	2,207,691								$	1,926	(*****)

(*)	Subject to changes as describe in the agreement.

(**)	Less than $0.01.

(***)

M&A or qualified public offering as described in the agreement.

(****)

Issued in connection with the 2019, 2017 and 2014 arrangements.

(*****)

Contains warrants presented at fair value within current liabilities.

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details